Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Overcome low levels of detection limit and choice of antibody affects detection of lipoarabinomannan in pediatric tuberculosis

PLoS ONE(2022)10.1371/journal.pone.0275838Source: DataRank Database

Overcome low levels of detection limit and choice of antibody affects detection of lipoarabinomannan in pediatric tuberculosis is a research paper published in PLoS ONE (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.29)OA: goldTopics (48)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Prithwiraj De ORCID,Barbara Graham ORCID,Brooke L. Jensen,Emmanuel Moreau ORCID,Delphi Chatterjee ORCID

Live enrichment

PubMed:36219600 PMC:PMC9553055 OpenAlex:https://openalex.org/W4304481088

National Institute of Allergy and Infectious Diseases

Grant: AI132680

NIH/NAID

Grant: U19 AI109755

NIAID NIH HHS

Grant: R01 AI132680

National Institutes of Health

Grant: 1U19AI109755-01

Genetic determinants of drug resistance in Mycobacteria tuberculosis

National Institutes of Health

Grant: 1R01AI132680-01A1

Validation of urine/serum LAM in HIV/nonHIV TB suspects and POC Test Development

FWCI

0.29

Citation Percentile

0.5%

Citation Trend

2023

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0275838&type=printable

GOLDhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0275838&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0275838&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0275838

journalhttps://doi.org/10.1371/journal.pone.0275838

Fields of Study

Tuberculosis Research and EpidemiologyMycobacterium research and diagnosisPneumonia and Respiratory InfectionsMedicine0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AdolescentAdultAntibodiesEpitopesChildHumansLipopolysaccharidesMycobacterium tuberculosisSensitivity and SpecificityTuberculosisHIV InfectionsLimit of Detection

Keywords

LipoarabinomannanMedicineTuberculosisAntibodyArea under the curveReceiver operating characteristicUrineEpitopeDetection limitMycobacterium tuberculosisInternal medicineImmunologyChromatographyPathologyChemistryAdultLipopolysaccharidesAdolescentScienceQRHIV InfectionsSensitivity and SpecificityAntibodiesEpitopesLimit of DetectionHumansChildResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being